Dermata Therapeutics Inc (DRMA)

Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	56.44%3.01	1.93	1.90	1.76	1.77
Selling, General, and Administrative	81.57%2.80	1.54	1.37	1.26	-
Research and Development	44.61%0.21	0.38	0.53	0.50	0.62
Operating Income/Loss	56.44%-3.01	-1.93	-1.90	-1.76	-1.77
	60.58%-2.97	-1.85	-1.86	-1.69	-1.70
Attributable To Parent	60.58%-2.97	-1.85	-1.86	-1.69	-1.70
Basic Average Shares	4.23%4.02	3.86	-	1.03	1.03
Diluted Average Shares	4.23%4.02	3.86	-	1.03	1.03
Basic Earnings Per Share	54.17%-0.74	-0.48	-	-1.65	-1.66
Diluted Earnings Per Share	54.17%-0.74	-0.48	-	-1.65	-1.66